Does Routine Anti-Osteoporosis Medication Lower the Risk of Fractures in Male Subjects? An Updated Systematic Review With Meta-Analysis of Clinical Trials

Does Routine Anti-Osteoporosis Medication Lower the Risk of Fractures in Male Subjects? An Updated Systematic Review With Meta-Analysis of Clinical Trials

Background: Several epidemiological articles have reported the correlations between anti-osteoporosis medication and the risks of fractures in male and female subjects, but the specific efficacy of anti-osteoporosis medication for male subjects remains largely unexplored.Objective: The aim of this s...

Full description

Bibliographic Details
Main Authors: Ling-Feng Zeng, Bi-Qi Pan, Gui-Hong Liang, Ming-Hui Luo, Ye Cao, Da Guo, Hong-Yun Chen, Jian-Ke Pan, He-Tao Huang, Qiang Liu, Zi-Tong Guan, Yan-Hong Han, Di Zhao, Jin-Long Zhao, Sen-Rong Hou, Ming Wu, Jiong-Tong Lin, Jia-Hui Li, Wei-Xiong Liang, Ai-Hua Ou, Qi Wang, Wei-Yi Yang, Jun Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-08-01
Series:Frontiers in Pharmacology
Subjects:
anti-osteoporosis medication
routine therapy
osteoporotic fracture
clinical trials
risk reduction
literature review
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00882/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2019.00882/full

Similar Items